Switch to
More onapp

How to use scorecard? Learn more

Nath Bio-Genes (I) Ltd

NATHBIOGEN
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹318 cr, stock is ranked 1,572
Moderate RiskStock is 2.95x as volatile as Nifty
172.905.40 (+3.22%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't faired well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Consumer StaplesAgro Products
SmallcapWith a market cap of ₹318 cr, stock is ranked 1,572
Moderate RiskStock is 2.95x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
0.59
Dividend YieldDiv. Yield
1.19%
Sector PESector PE
46.25
Sector PBSector PB
9.93
Sector Div YldSctr Div Yld
1.38%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nath Bio-Genes (India) is engaged in hybrid seed business and production, processing and marketing of hybrid and genetically modified (GM) seeds

Investor PresentationView older 

Apr 22, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

2020202120222023281.71309.23280.21301.9250.4955.65-67.3435.04
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Annual Secretarial Compliance Report 
Announced OnMay 27, 2023

Annual Secretarial Compliance Report for the financial year ended 31st March 2023. | Download

Annual Secretarial Compliance Report for the financial year ended 31st March 2023. | Download

Revised Book Closure 
Announced OnMay 23, 2023

Nath Bio-Genes (India) Limited had intimated the Exchange that the Register of Members & Share Transfer Books of the Company shall remain closed from 25-Jun-2023 to 30-Jun-2023. The Company has now informed the Exchange that the Register of Members & Share Transfer Books of the Company will now remain closed from 05-Jul-2023 to 11-Jul-2023 for the purpose of Dividend & Meeting. | Download

Nath Bio-Genes (India) Limited had intimated the Exchange that the Register of Members & Share Transfer Books of the Company shall remain closed from 25-Jun-2023 to 30-Jun-2023. The Company has now informed the Exchange that the Register of Members & Share Transfer Books of the Company will now remain closed from 05-Jul-2023 to 11-Jul-2023 for the purpose of Dividend & Meeting. | Download

Cash Dividend 
Ex. DateJun 23, 2022

Final • Div/Share: ₹ 2

See all events